Autoclustering of Non-small Cell Lung Carcinoma Subtypes on 18F-FDG PET Using Texture Analysis: A Preliminary Result

Nuclear Medicine and Molecular Imaging

Volumn 48, Issue 4, 2014, Pages 278-286

  Ha, Seunggyun ^a,b   Choi, Hongyoon ^a,b   Cheon, Gi Jeong ^a,c,e   Kang, Keon Wook ^a,c   Chung, June Key ^a,c   Kim, Euishin Edmund ^b,d   Lee, Dong Soo ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University   (South Korea)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Seoul National University College of Medicine   (South Korea)

Author keywords

Carcinoma; Cluster analysis; F 18 Fluorodeoxyglucose; Non small cell lung; Positron emission tomography; Texture analysis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BIOPSY; CELL HETEROGENEITY; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MALE; METABOLISM; NON SMALL CELL LUNG CANCER; PET-CT SCANNER; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TUMOR VOLUME; VERY ELDERLY;

EID: 84919913551     PISSN: 18693474     EISSN: 18693482     Source Type: Journal    
DOI: 10.1007/s13139-014-0283-3     Document Type: Article

References (28)

1. Jung K-W, Park S, Kong H-J, Won Y-J, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012;44(1):11–24.
2. Podbielski FJ, Rodriguez HE, Brown AM, Blecha MJ, Salazar MR, Connolly MM. Percutaneous biopsy in evaluation of lung nodules. JSLS. 2004;8(3):213–6.
3. Han B, Lin S, Yu L-J, Wang R-Z, Wang Y-Y. Correlation of 18F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancer. Nucl Med Commun. 2009;30(11):831–7.
4. Rahim MK, Kim SE, So H, Kim HJ, Cheon GJ, Lee ES, et al. Recent trends in PET image interpretations using volumetric and texture-based quantification methods in nuclear oncology. Nucl Med Mol Imaging. 2014:1-15.
5. Budiawan H, Cheon GJ, Im H-J, Lee SJ, Paeng JC, Kang KW, et al. Heterogeneity analysis of 18F-FDG uptake in differentiating between metastatic and inflammatory lymph nodes in adenocarcinoma of the lung: comparison with other parameters and its application in a clinical setting. Nucl Med Mol Imaging. 2013;47(4):232–41.
6. Castellano G, Bonilha L, Li LM, Cendes F. Texture analysis of medical images. Clin Radiol. 2004;59(12):1061–9.
7. Collewet G, Strzelecki M, Mariette F. Influence of MRI acquisition protocols and image intensity normalization methods on texture classification. Magn Reson Imaging. 2004;22(1):81–91.
8. Materka A. MaZda user’s manual. Available at: http://www.eletel.p.lodz.pl/cost/progr_mazda_eng.html. 2002.
9. Balakrishnama S, Ganapathiraju A. Linear discriminant analysis—a brief tutorial. Institute for Signal and information Processing, Mississippi State University, Starkville. 1998.
10. Saif MW, Tzannou I, Makrilia N, Syrigos K. Role and cost effectiveness of PET/CT in management of patients with cancer. Yale J Biol Med. 2010;83(2):53.
11. Choi ES, Ha SG, Kim HS, Ha JH, Paeng JC, Han I. Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma. Eur J Nucl Med Mol Imaging. 2013;40(12):1836–42.
12. Im H-J, Kim YK, Kim Y-i, Lee JJ, Lee WW, Kim SE. Usefulness of combined metabolic–volumetric indices of 18F-FDG PET/CT for the early prediction of neoadjuvant chemotherapy outcomes in breast cancer. Nucl Med and Mole Imaging. 2013:1-8.
13. Hatt M, Visvikis D, Albarghach NM, Tixier F, Pradier O, Cheze-le RC. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology. Eur J Nucl Med Mol Imaging. 2011;38(7):1191–202.
14. Holli K, Laaperi AL, Harrison L, Luukkaala T, Toivonen T, Ryymin P, et al. Characterization of breast cancer types by texture analysis of magnetic resonance images. Acad Radiol. 2010;17(2):135–41.
15. Davnall F, Yip CS, Ljungqvist G, Selmi M, Ng F, Sanghera B, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012;3(6):573–89.
16. Ba-Ssalamah A, Muin D, Schernthaner R, Kulinna-Cosentini C, Bastati N, Stift J, et al. Texture-based classification of different gastric tumors at contrast-enhanced CT. Eur J Radiol. 2013;82(10):e537–43.
17. Cook GJ, Yip C, Siddique M, Goh V, Chicklore S, Roy A, et al. Are pretreatment 18F-FDG PET tumor textural features in non–small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med. 2013;54(1):19–26.
18. Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010;362(25):2380–8.
19. Vesselle H, Salskov A, Turcotte E, Wiens L, Schmidt R, Jordan CD, et al. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index. J Thorac Oncol. 2008;3(9):971–8.
20. Choi H, Paeng JC, Kim D-W, Lee JK, Park CM, Kang KW, et al. Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT. Lung Cancer. 2012;79(3):242-7.
21. Putora PM, Fruh M, Muller J. FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma. Respirology. 2013;18(4):734–5.
22. Cheng NM, Fang YH, Yen TC. The promise and limits of PET texture analysis. Ann Nucl Med. 2013;27(9):867–9.
23. Wu H, Sun T, Wang J, Li X, Wang W, Huo D, et al. Combination of radiological and gray level co-occurrence matrix textural features used to distinguish solitary pulmonary nodules by computed tomography. J Digit Imaging. 2013;26(4):797–802.
24. Chicklore S, Goh V, Siddique M, Roy A, Marsden PK, Cook GJ. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis. Eur J Nucl Med Mol Imaging. 2013;40(1):133–40.
25. Ye J, Janardan R, Li Q. Two-dimensional linear discriminant analysis. In: Advances in neural information processing systems. San Mateo: Morgan Kaufmann Publishers; 2004.
26. Larson SM. Cancer or inflammation? A holy grail for nuclear medicine. J Nucl Med. 1994;35(10):1653–5.
27. Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G, et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med. 2003;44(9):1426–31.
28. Galavis PE, Hollensen C, Jallow N, Paliwal B, Jeraj R. Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters. Acta Oncol. 2010;49(7):1012–6.